Now enrolling

Current Studies

Browse our currently enrolling clinical trials across behavioral health, neuroscience, and specialty medicine. If something looks like a fit, reach out — our team will walk you through eligibility and next steps. Participation is always voluntary.

Open studies

Currently enrolling

Each study links to its listing on ClinicalTrials.gov for full protocol details. Not sure if you qualify? Reach out and we’ll help you find out.

Behavioral Health
Enrolling

Major Depressive Disorder

A Phase 2 study of zelquistinel, an investigational oral NMDA-receptor modulator, for adults living with major depressive disorder.

Worcester, MA
Phase 2
NCT07115329 ↗

See if I qualify →

Behavioral Health
Enrolling

Treatment-Resistant Depression

A study of ALTO-207 for adults living with treatment-resistant depression who have not responded adequately to prior antidepressant treatment.

Worcester, MA
Adults 18+
NCT07553637 ↗

See if I qualify →

Behavioral Health
Enrolling

Major Depressive Disorder · Ascend

A Phase 3 study (Ascend) of DT-120, an investigational medication, for adults living with major depressive disorder.

Worcester, MA
Phase 3
NCT07592689 ↗

See if I qualify →

Neuroscience · Sleep
Enrolling

Pediatric Insomnia

A Phase 3 study of tasimelteon versus placebo for children with insomnia disorder.

Worcester, MA · Myrtle Beach, SC
Phase 3
NCT06953869 ↗

See if I qualify →

Neuroscience · Dementia
Enrolling

Agitation in Alzheimer’s Disease

A Phase 3 study of an investigational medication for agitation associated with Alzheimer’s disease dementia.

Worcester, MA
Phase 3
NCT07011745 ↗

See if I qualify →

Behavioral Health
Enrolling

Post-Traumatic Stress Disorder

A Phase 3 study of an investigational medication for adults living with post-traumatic stress disorder.

Worcester, MA
Phase 3
NCT07456696 ↗

See if I qualify →

Behavioral Health
Enrolling

Major Depressive Disorder · Inadequate Response

A Phase 2 study for adults with major depressive disorder who have not responded adequately to antidepressant treatment.

Worcester, MA
Phase 2
NCT07284667 ↗

See if I qualify →

Behavioral Health
Enrolling

Major Depressive Disorder · Moderate-to-Severe

A Phase 3 study of an investigational medication for adults with moderate-to-severe major depressive disorder.

Worcester, MA
Phase 3
NCT07076407 ↗

See if I qualify →

New studies open regularly

Don’t see your condition? Join our registry and we’ll reach out when a matching trial opens.

Join our registry →

Before you apply

What to expect when you reach out

Our process is simple, private, and pressure-free. Learn more about how clinical trials work →

1

We reach out within 1 business day

A real member of our patient engagement team — not a bot — will contact you directly to answer questions.

2

A short phone pre-screening

We ask a few questions to see if a current study could be a match. About 10 minutes, no commitment.

3

An in-person visit to learn more

If you qualify, visit our site to meet the team and decide if you’d like to take part.

Get started

Ready to see if you qualify?

Reach out and our team will walk you through the process. No pressure, no commitment — just a conversation.